Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, 13288 Marseille, France.
Centre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS, 13288 Marseille, France.
Sci Immunol. 2020 Mar 13;5(45). doi: 10.1126/sciimmunol.aba1896.
Conventional dendritic cells expressing the XCR1 chemokine receptor (cDC1s) excel at cross-presentation. Here, we developed and used a mouse model in which a Cre recombinase is expressed under the control of the gene while preserving XCR1 expression. We used it to generate mice with conditional deletion of MHC class II (MHCII) molecules on cDC1s. By preventing cDC1s to receive suppressive regulatory T cell inputs via MHCII-restricted interactions, the objective of the present study was to gauge whether MHCII-deficient cDC1s lose their capacity of tolerizing autoreactive CD8 T cells. Whereas MHCII cDC1 readily cross-tolerized strongly autoreactive CD8 T cells specific for a keratinocyte-derived self-antigen, MHCII-deficient cDC1s converted them into potent effectors capable of triggering a fast-onset lethal autoimmunity associated with severe skin histopathological manifestations. Preventing egress of such pathogenic self-reactive CD8 T cell effectors from the cutaneous draining lymph nodes abrogated the autoimmune condition. Therefore, our results revealed that the cross-tolerizing capacity of cDC1s is not a property fully acquired at the time they undergo homeostatic maturation but needs to be enforced via MHCII-restricted, suppressive interactions with regulatory T cells.
表达 XCR1 趋化因子受体(cDC1s)的常规树突状细胞擅长交叉呈递。在这里,我们开发并使用了一种小鼠模型,其中 Cre 重组酶在 基因的控制下表达,同时保留 XCR1 的表达。我们用它来生成 cDC1s 上 MHC II 类分子(MHCII)条件性缺失的小鼠。通过防止 cDC1s 通过 MHCII 限制的相互作用接收抑制性调节性 T 细胞的输入,本研究的目的是评估 MHCII 缺陷的 cDC1s 是否丧失耐受自身反应性 CD8 T 细胞的能力。虽然 MHCII cDC1 很容易交叉耐受对角质细胞衍生的自身抗原具有强烈自身反应性的 CD8 T 细胞,但 MHCII 缺陷的 cDC1 将它们转化为能够触发快速发作的致命自身免疫的有效效应物,伴有严重的皮肤组织病理学表现。阻止这些致病性自身反应性 CD8 T 细胞效应物从皮肤引流淋巴结中逸出可消除自身免疫状态。因此,我们的结果表明,cDC1 的交叉耐受能力不是它们经历稳态成熟时完全获得的特性,而是需要通过 MHCII 限制的、与调节性 T 细胞的抑制性相互作用来加强。